Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 1550 Orleans St, 492 CRB II, Baltimore, MD 21231, USA.
Radiology. 2010 Feb;254(2):577-86. doi: 10.1148/radiol.09081867.
To develop a relevant pathophysiologic model of human immunodeficiency virus (HIV)-associated dementia by studying regional variations in metabolite levels measured with magnetic resonance (MR) spectroscopic imaging and their relationship to immunologic measures and cognitive dysfunction.
This was a HIPAA-compliant, institutional review board-approved study involving written informed consent. Distributions of N-acetylaspartate (NAA), choline (Cho), and creatine (Cr) concentrations in 94 subjects (20 seronegative controls and 74 HIV-positive subjects; 34 of the HIV-positive subjects having HIV-associated dementia; 63 men, 31 women; mean age, 40 years) were determined with proton (hydrogen 1 [(1)H]) MR spectroscopic imaging. HIV-positive subjects underwent neuropsychological testing and blood and cerebrospinal fluid (CSF) analysis. Factor analysis was utilized to determine associations between metabolites across regions. Analysis of variance and t tests were used to isolate differences between cohorts.
A "Cho factor" differentiated seronegative controls from HIV-infected cohorts, indicating elevated Cho levels across deep gray and white matter regions of HIV-positive individuals. An "NAA factor" differentiated those with dementia from those without and correlated best with psychomotor and executive function tests. A "Cr factor" indicated Cr elevations correlated with CSF monocyte chemoattractant protein-1 levels. NAA and Cr factor scores were strongly weighted to metabolite changes in white matter regions.
These results highlight the importance of white matter involvement in HIV-associated dementia and support the current pathogenesis model of glial cell proliferation in HIV infection, denoted by regional Cho elevations, and neuronal dysfunction and/or death, denoted by NAA decreases, associated with dementia. Factor analysis of MR spectroscopic imaging data is a useful method for determining regional metabolic variations in HIV infection and its neuropsychological correlates.
通过研究磁共振(MR)光谱成像测量的代谢物水平的区域变化及其与免疫测量和认知功能障碍的关系,建立人类免疫缺陷病毒(HIV)相关痴呆的相关病理生理模型。
这是一项符合 HIPAA 规定、机构审查委员会批准的研究,包括书面知情同意书。在 94 名受试者(20 名血清阴性对照和 74 名 HIV 阳性受试者;34 名 HIV 阳性受试者患有 HIV 相关痴呆;63 名男性,31 名女性;平均年龄 40 岁)中,通过质子(氢 1 [(1)H])MR 光谱成像确定 N-乙酰天冬氨酸(NAA)、胆碱(Cho)和肌酸(Cr)浓度的分布。对 HIV 阳性受试者进行神经心理学测试和血液及脑脊液(CSF)分析。利用因子分析确定跨区域代谢物之间的关联。方差分析和 t 检验用于分离队列之间的差异。
“Cho 因子”将血清阴性对照与 HIV 感染队列区分开来,表明 HIV 阳性个体的深部灰质和白质区域的 Cho 水平升高。“NAA 因子”将痴呆与非痴呆患者区分开来,与精神运动和执行功能测试相关性最好。“Cr 因子”表明 Cr 升高与 CSF 单核细胞趋化蛋白-1 水平相关。NAA 和 Cr 因子评分主要与白质区域的代谢物变化有关。
这些结果强调了 HIV 相关痴呆中白质受累的重要性,并支持目前的发病机制模型,即 HIV 感染中的神经胶质细胞增殖,表现为 Cho 升高,以及与痴呆相关的神经元功能障碍和/或死亡,表现为 NAA 降低。MR 光谱成像数据的因子分析是确定 HIV 感染及其神经心理学相关性的区域代谢变化的有用方法。